
Rabeta IV 20mg Injection
Marketer
Avita Laboratories Pvt Ltd
Salt Composition
Rabeprazole (20mg)
Overview Rabeta IV 20mg Injection
Injex 20mg IV is a rapid-acting medication that diminishes gastric acid production. Indicated for various acid-related gastrointestinal disorders including reflux, indigestion, peptic ulcers, and other hyperacidity conditions, it offers swift relief from acidity symptoms. Furthermore, it's utilized for preventing stress ulcers in critically ill patients and pre-anesthetically to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), Injex 20mg IV is administered intravenously by a medical professional only when deemed preferable to oral administration. Dosage and treatment length are determined by your physician based on individual needs and response. Optimal treatment involves smaller, more frequent meals and avoidance of caffeine, spicy foods, and fatty foods. Common, generally mild, adverse effects include nausea, vomiting, headache, dizziness, gas, diarrhea, stomach pain, and thrombophlebitis (vein inflammation). Persistent or bothersome symptoms warrant medical attention. Prolonged use, particularly exceeding one year, may elevate fracture risk, especially at higher doses. Consult your doctor about mitigating osteoporosis risk, such as through calcium and vitamin D supplementation. Hypomagnesemia (low magnesium) has been reported after three months or more of use, possibly causing fatigue, confusion, dizziness, muscle spasms, and arrhythmias. Your doctor may monitor your magnesium levels. Injex 20mg IV is contraindicated for individuals with severe hepatic impairment, those on HIV medications, those with a history of PPI allergy, or those with osteoporosis. Pregnant or lactating individuals should consult their physician before use. Alcohol consumption should be avoided due to its acid-stimulating effects. Refrain from operating machinery if dizziness or drowsiness occurs.
Uses of Rabeta IV 20mg Injection
Managing acid reflux and peptic ulcers
Major Benefits of Rabeta IV 20mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Rabeta IV 20mg Injection:
- Nausea
- Vomiting
- Headache
- Dizziness
- Flatulence
- Diarrhea
- Stomach pain
- Thrombophlebitis
How to use Rabeta IV 20mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Rabeta IV 20mg Injection works:
Protium 20mg intravenous injection, a proton pump inhibitor, lessens gastric acid production, providing symptomatic relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Rabeta IV 20mg Injection requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Rabeta IV 20mg Injection during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administration of Rabeta IV 20mg Injection while breastfeeding is likely inadvisable. Available human data indicates potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The impact of Rabeta IV 20mg Injection on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Patients with kidney impairment can safely receive Rabeta IV 20mg Injection without requiring a modified dosage.
LiverCAUTION
Administering Rabeta IV 20mg Injection requires careful consideration in individuals with advanced hepatic impairment. Dosage modification for Rabeta IV 20mg Injection may be necessary. Physician consultation is advised.
What if you forget to take Rabeta IV 20mg Injection :
Omit a dose of Rabeta IV 20mg Injection? Seek your physician's advice.
Facts to Know About Rabeta IV 20mg Injection
| Label | Value |
|---|---|
| Type of Compound | Benzimidazole sulfone compound |
| Potential for Dependence | None. |
| Type of Treatment | Digestive system |
| Mechanism of Action | Gastric acid secretion suppressants |
